KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (CCAP) EBITDA (2021 - 2025)

Crescent Capital BDC's EBITDA history spans 5 years, with the latest figure at $141.8 million for Q4 2025.

  • For Q4 2025, EBITDA rose 180.86% year-over-year to $141.8 million; the TTM value through Dec 2025 reached $66.9 million, up 126.11%, while the annual FY2025 figure was $66.9 million, 162.67% up from the prior year.
  • EBITDA reached $141.8 million in Q4 2025 per CCAP's latest filing, up from -$24.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $141.8 million in Q4 2025 to a low of -$175.3 million in Q4 2024.
  • Average EBITDA over 5 years is -$10.8 million, with a median of -$22.9 million recorded in 2023.
  • The largest YoY upside for EBITDA was 262.29% in 2023 against a maximum downside of 266.28% in 2023.
  • A 5-year view of EBITDA shows it stood at $80.9 million in 2021, then increased by 21.32% to $98.2 million in 2022, then plummeted by 263.04% to -$160.1 million in 2023, then fell by 9.53% to -$175.3 million in 2024, then skyrocketed by 180.86% to $141.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCAP's EBITDA are $141.8 million (Q4 2025), -$24.1 million (Q3 2025), and -$25.7 million (Q2 2025).